Oct. 27 at 12:40 PM
$SCNX guys stop making bets and think and do your own research. The shorts don't know what they are shorting also.
This company released a new product.(losartan)
In a US Market there are
$256 million annual prescriptions. This product is a need for the patients who cannot swallow tablets, such as children over six and elderly adults with dysphagia.
This medication dies not require refrigeration and has a 24 months shelf life at room temperature.
The stock drops because it was a share dilution and the shorts profited.
The capital rise it was a must.
You can check my previous post also.
DO YOUR OWN DD AND STOP RELY ON OTHERS.